In vitro effects of human recombinant alpha-2b interferon on Ph1+ chronic myelogenous leukemia cells maintained in long term marrow cultures: a functional and morphological analysis

J Biol Regul Homeost Agents. 1989 Jul-Sep;3(3):102-7.

Abstract

In this study in vitro results obtained with hu rec IFN-alpha 2b on Ph1+ stem cells from patients with chronic myelogenous leukemia in chronic phase (CML in CP) will be discussed: cells were incubated with different IFN concentrations (100, 1000, 10000 IU/ml) for different times (24, 96 hrs, 8, 15, days) and maintained in long term marrow cultures (LTMC); CFU-GM assay, cytochemistry and cytogenetic analyses were performed weekly. A high sensitivity of CML cells to the in vitro treatment with IFN was observed. Cell count in LTMC showed a progressive reduction inversely proportional to time of incubation and concentration of IFN; a marked decrease in colony growth was observed at the end of incubations and during the course of LTMC. Low concentrations of IFN permitted a morphological maturation and the expression of alkaline phosphatase. Cytogenetic analyses showed a marked reduction of mytoses in cultures treated with high concentrations of IFN as result of a combined cytostatic and cytolitic effect; the persistance of 100% Ph1+ cells in LTMC and in CFU-GM colonies might be related, as opposed to in vivo results, to different IFN exposure conditions or might be influenced by other factors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Marrow Cells
  • Cells, Cultured
  • Cytogenetics
  • Histocytochemistry
  • Humans
  • Interferon Type I / pharmacology*
  • Interferon alpha-2
  • Interferon-alpha / pharmacology*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology*
  • Neoplastic Stem Cells / pathology
  • Recombinant Proteins
  • Stem Cells
  • Tumor Cells, Cultured

Substances

  • Interferon Type I
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins